Europe is expected to provide enormous growth opportunities for DNA Synthesis, with a high share of 27.9% by 2032

The DNA Synthesis Market is expected to grow at a 7.7% CAGR during the forecast period. In 2022, the market is expected to be worth US$ 261.9 million, rising to US$ 592.1 million in 2032.

the DNA synthesis market is fueled by the growing application of the same in different end-use industries like agricultural science, food science, immunology, antibody discovery, cancer research, infectious diseases, and synthetic biology. Hence, the DNA synthesis market looks forward to robust prospects during the forecast period.

The natural creation of nucleic acid strands through DNA replication is referred to as DNA synthesis. They are synthesized artificially using genetic engineering and enzyme chemistry in a laboratory environment. The synthesized version is then used for various purposes and applications like therapeutic, diagnostics, and academic and industrial research. With a surge in the popularity of DNA synthesis, these applications have also increased in the past few years.

Request for a sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-5900

The growing adoption of gene therapy has contributed to the rise in the need for rapid gene synthesis products. These products provide accurate gene sequences in a short period of time. It enhances the body’s ability to fight against infection and diseases. The utilization of DNA synthesis is increasingly becoming important so as to avoid any alteration to DNA which may result in oncological diseases. In addition to this, the demand for DNA synthesis is also escalating due to its ability to repair the disease of premature ageing.

The process of Nucleotide synthesis is complex and involves multiple enzymes and proteins working together in a coordinated manner. It is regulated at various checkpoints to ensure that errors are minimized and the DNA is faithfully replicated.

The synthetic biology segment is a primary growth driver of the DNA synthesis market and accounts for a major share. Again, growing research and development associated with gene synthesis along with constant advancements made in the technological processes such as molecular separation and protein purification technology which assist in developing reliable, fast, and cost-effective solutions also contribute to the target market growth over the projected period.

“Rising application of DNA synthesis in areas like therapeutic, diagnostics, and academic and industrial research will drive the market growth of the same over the forecast period,” says an FMI analyst.  

Ask A Question: https://www.futuremarketinsights.com/ask-question/rep-gb-5900

Key Takeaways:

• Advancements in technological processes will strengthen the future possibilities of the DNA synthesis market.
• Extended wait for approvals of gene synthesizers and products may stunt the market growth.
• North America accounts for 30.2% of the global market share.
• The DNA synthesis market in Europe will likely hold 27.9% of the overall market share.

Competitive Landscape 

Brooks Automation, Inc. (GENEWIZ), Boster Biological Technology, ProteoGenix, Biomatik, ProMab Biotechnologies, Inc, Thermo Fisher Scientific, Inc, Integrated DNA Technologies, Inc, and OriGene Technologies, Inc., among others are some of the major players in the DNA synthesis market profiled in the full version of the report.

Leading market players are focusing on utilizing innovative marketing plans to achieve the highest profits. These enterprises are also keen on mergers, partnerships, and collaboration to strengthen their market presence.

Key Segments

By Service Type:

• Oligonucleotide DNA Synthesis
• Universal Oligonucleotide DNA Synthesis
• Custom Oligonucleotide DNA Synthesis
• Gene DNA Synthesis
• Custom Gene DNA Synthesis
• Gene Library DNA Synthesis

Use promo code ->> FMITODAY to get a flat 20% discount

By Application:

• DNA Synthesis for Research and Development
• DNA Synthesis for Academic Applications
• DNA Synthesis for Industrial Applications
• DNA Synthesis for Diagnosis
• DNA Synthesis for Therapeutics

By End User:

• DNA Synthesis for Biopharmaceutical Companies
• DNA Synthesis for Academic and Research Institutes
• DNA Synthesis for Contract Research Organizations

Explore Wide-ranging Coverage of FMI’s Healthcare Landscape:

• https://bpa-mastery.mn.co/posts/32878592
• https://marketresearch89.wordpress.com/2023/02/23/laband-syndrome-therapeutics-market-to-reach-us-5-billion-by-2033-fmi-study/
• https://community.wongcw.com/blogs/363537/Laband-Syndrome-Therapeutics-Market-to-reach-US-5-Billion-by

About Future Market Insights (FMI)

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs